These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7900497)

  • 1. Pharmacokinetics of etretinate and acitretin with special reference to treatment of psoriasis.
    Larsen FG
    Acta Derm Venereol Suppl (Stockh); 1994; 190():1-33. PubMed ID: 7900497
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions.
    Park HD; Kim HK; Kim JW; Kim DW; Lee JH; Huh W; Youn JI; Kim HG; Kim YG; Kim MH; Lee SY
    Transfusion; 2008 Nov; 48(11):2395-400. PubMed ID: 18657077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Trans-acitretin is metabolized back to etretinate. Importance for oral retinoid therapy].
    Almond-Roesler B; Orfanos CE
    Hautarzt; 1996 Mar; 47(3):173-7. PubMed ID: 8647698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis symposum. Retinoids.
    Lowe N
    Semin Dermatol; 1992 Dec; 11(4 Suppl 1):17-22. PubMed ID: 1493097
    [No Abstract]   [Full Text] [Related]  

  • 5. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
    Meffert H; Sönnichsen N
    Acta Derm Venereol Suppl (Stockh); 1989; 146():176-7. PubMed ID: 2532846
    [No Abstract]   [Full Text] [Related]  

  • 6. Inability to detect plasma etretinate and acitretin is a poor predictor of the absence of these teratogens in tissue after stopping acitretin treatment.
    Sturkenboom MC; de Jong-Van Den Berg LT; van Voorst-Vader PC; Cornel MC; Stricker BH; Wesseling H
    Br J Clin Pharmacol; 1994 Sep; 38(3):229-35. PubMed ID: 7826824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
    Bjerke JR; Geiger JM
    Acta Derm Venereol Suppl (Stockh); 1989; 146():206-7. PubMed ID: 2532847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and drug interactions of etretinate and acitretin.
    Lambert WE; Meyer E; De Leenheer AP; De Bersaques J; Kint AH
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 2):S19-22. PubMed ID: 1460119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of acitretin.
    Lambert WE; Meyer E; De Leenheer AP; De Bersaques J; Kint AH
    Acta Derm Venereol Suppl (Stockh); 1994; 186():122-3. PubMed ID: 8073811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
    Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
    Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of acitretin in severe psoriasis.
    Geiger JM
    Skin Therapy Lett; 2003; 8(4):1-3, 7. PubMed ID: 12858231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of psoriasis with retinoids: present status.
    Orfanos CE
    Cutis; 1999 Nov; 64(5):347-53. PubMed ID: 10582161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etretinate may work where acitretin fails.
    Bleiker TO; Bourke JF; Graham-Brown RA; Hutchinson PE
    Br J Dermatol; 1997 Mar; 136(3):368-70. PubMed ID: 9115918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teratogenic risk with etretinate and acitretin treatment.
    Geiger JM; Baudin M; Saurat JH
    Dermatology; 1994; 189(2):109-16. PubMed ID: 8075435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate and etretinate in the treatment of psoriasis.
    Vanderveen EE; Ellis CN
    Arch Dermatol; 1984 Dec; 120(12):1555-6. PubMed ID: 6508327
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature.
    Halverstam CP; Zeichner J; Lebwohl M
    J Cutan Med Surg; 2006; 10(6):291-9. PubMed ID: 17241599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An appraisal of acitretin therapy in children with inherited disorders of keratinization.
    Lacour M; Mehta-Nikhar B; Atherton DJ; Harper JI
    Br J Dermatol; 1996 Jun; 134(6):1023-9. PubMed ID: 8763418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acitretin prescribing patterns in women of childbearing potential.
    Davis SA; Yentzer BA; Feldman SR
    J Drugs Dermatol; 2013 Jul; 12(7):799-802. PubMed ID: 23884494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with acitretin and alcohol drinking: a high risk combination].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2001 Nov; 128(11):1269. PubMed ID: 11908183
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
    Katz HI
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.